Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving hundreds of leading biopharmaceutical companies globally:

Accenture
Merck
Covington
Federal Trade Commission
Daiichi Sankyo
Chubb

Generated: September 22, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR BELBUCA

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Clinical Trials for Belbuca

Trial ID Title Status Sponsor Phase Summary
NCT00941304 Study of Buprenorphine HCl Buccal Film in the Treatment of Dental Pain Completed Endo Pharmaceuticals Phase 2 The purpose of this study is to assess the activity of buprenorphine hydrochloride (HCl) buccal film in the treatment of dental pain.
NCT01256450 Efficacy and Safety Study of Buprenorphine HCl Buccal Film in Subjects With Low Back Pain Completed Endo Pharmaceuticals Phase 3 The purpose of this study is to determine whether buprenorphine hydrochloride (HCl) buccal film is effective and safe in the treatment of chronic low back pain (CLBP).
NCT01633944 Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects Completed BioDelivery Sciences International Phase 3 The purpose of this study is to determine if buprenorphine hydrochloride (HCl) buccal film is effective in treating opioid-naive subjects, with moderate to severe chronic low back pain (CLBP), who require continuous around-the-clock (ATC) pain relief for an extended period of time.
NCT01633944 Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects Completed Endo Pharmaceuticals Phase 3 The purpose of this study is to determine if buprenorphine hydrochloride (HCl) buccal film is effective in treating opioid-naive subjects, with moderate to severe chronic low back pain (CLBP), who require continuous around-the-clock (ATC) pain relief for an extended period of time.
NCT01675167 Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects Completed BioDelivery Sciences International Phase 3 The purpose of the study is to determine if buprenorphine hydrochloride (HCl) buccal film is effective in treating opioid-experienced subjects, with moderate to severe chronic low back pain (CLBP), who require continuous around-the-clock (ATC) pain relief for an extended period of time.
NCT01675167 Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects Completed Endo Pharmaceuticals Phase 3 The purpose of the study is to determine if buprenorphine hydrochloride (HCl) buccal film is effective in treating opioid-experienced subjects, with moderate to severe chronic low back pain (CLBP), who require continuous around-the-clock (ATC) pain relief for an extended period of time.
NCT01871285 Evaluation of the Tolerability of Switching Subjects on Chronic ATC Opioid Therapy to Buprenorphine HCl Buccal Film Completed Endo Pharmaceuticals Phase 2 The primary aim of this study is to determine if chronic pain subjects on around-the-clock opioids who are receiving 100 to 220 mg oral morphine sulfate equivalent (MSE) can be safely transitioned on to buprenorphine hydrochloride (HCl) buccal film at 50% of their MSE dose without inducing opioid withdrawal or reversing analgesic effects.
>Trial ID >Title >Status >Phase >Summary

Clinical Trial Conditions for Belbuca

Condition Name

Condition Name for Belbuca
Intervention Trials
Low Back Pain 3
Pain 2
Dental Pain 1
Ventilatory Response to Hypercapnia (VRH) 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Belbuca
Intervention Trials
Low Back Pain 3
Back Pain 3
Hypercapnia 1
Toothache 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Belbuca

Trials by Country

Trials by Country for Belbuca
Location Trials
United States 70
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Belbuca
Location Trials
Utah 6
Kansas 4
Texas 4
Pennsylvania 4
Georgia 3
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Belbuca

Clinical Trial Phase

Clinical Trial Phase for Belbuca
Clinical Trial Phase Trials
Phase 4 1
Phase 3 3
Phase 2 2
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Belbuca
Clinical Trial Phase Trials
Completed 5
Not yet recruiting 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Belbuca

Sponsor Name

Sponsor Name for Belbuca
Sponsor Trials
Endo Pharmaceuticals 5
BioDelivery Sciences International 3
PRA Health Sciences 1
[disabled in preview] 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Belbuca
Sponsor Trials
Industry 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Daiichi Sankyo
Covington
Queensland Health
Baxter
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.